RNA sequencing(RNA-seq)was used to examine changes in the expression of BCL2 family proteins in samples from patients with CLL, MEC1 cell lines, and ibrutinib-resistant cell lines(MR). This evidence concerns the gene BCL2 and B-cell chronic lymphocytic leukemia.